Surgical specialties

Camber Spine Receives FDA Clearance for SPIRA-P and SPIRA-T Technologies

Retrieved on: 
Tuesday, August 3, 2021

Camber Spine , a leading innovator in spine and medical technologies, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for both its SPIRA-P Posterior Lumbar Spacer technology and SPIRA-T Oblique Posterior Lumbar Spacer technologies.

Key Points: 
  • Camber Spine , a leading innovator in spine and medical technologies, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for both its SPIRA-P Posterior Lumbar Spacer technology and SPIRA-T Oblique Posterior Lumbar Spacer technologies.
  • The SPIRA-T Oblique Posterior Lumbar Spacer features the same qualities, but is designed specifically to accommodate traditional or insert and rotate TLIF procedures.
  • Innovative spine and medical technology company Camber Spine Technologies is dedicated to creating surgeon-designed solutions in MIS and minimally disruptive access for the treatment of complex spinal pathology.
  • Incorporating state-of-the-art manufacturing, 3-D printing, and an acute sensitivity to patient anatomy, Camber Spine is making quantum leaps in the spinal fusion market.

USOSM Enters 15th State: Partners with Center for Oral and Facial Surgery of California

Retrieved on: 
Tuesday, August 3, 2021

Oral Surgery Management (USOSM) a specialty management services company that exclusively serves premier oral and maxillofacial surgeons is thrilled to announce a new partnership with the Center for Oral & Facial Surgery.

Key Points: 
  • Oral Surgery Management (USOSM) a specialty management services company that exclusively serves premier oral and maxillofacial surgeons is thrilled to announce a new partnership with the Center for Oral & Facial Surgery.
  • The Center for Oral & Facial Surgery has two offices treating patients in San Diego and in El Cajon, California.
  • "We're excited to announce our first partnership in California and are honored that it's with the Center for Oral & Facial Surgery, one of the oldest and most respected oral and maxillofacial surgery practices in the state.
  • Throughout San Diego County, the Center for Oral & Facial Surgery is a trusted name that stands for excellence and quality care.

Olney Center for Oral and Maxillofacial Surgery Introduces New Technology For Facial Cosmetic Procedures

Retrieved on: 
Tuesday, July 27, 2021

This procedure was added to Olney Center for Oral and Maxillofacial Surgery services due to Dr. Tebyanian's interest in assisting his patients in achieving a youthful appearance.

Key Points: 
  • This procedure was added to Olney Center for Oral and Maxillofacial Surgery services due to Dr. Tebyanian's interest in assisting his patients in achieving a youthful appearance.
  • This led to Olney Center for Oral and Maxillofacial Surgery's announcement of their deployment of new groundbreaking technology, called EmbraceRF.
  • The EmbraceRF procedures are best for:
    Patients who had facial cosmetic surgery but have relapses and need maintenance.
  • Dr. Anis Tebyanian is a highly regarded, board-certified Oral and Maxillofacial Surgeon that specializes in oral and maxillofacial surgery, anesthesia, general surgery, plastic surgery, head, and neck surgery, and facial trauma.

Asensus Surgical Announces the Appointment of Two New Board Members

Retrieved on: 
Monday, July 26, 2021

She currently serves as the Deputy Chief Clinical Officer at Anthem, Inc., a position she has held since December 2020.

Key Points: 
  • She currently serves as the Deputy Chief Clinical Officer at Anthem, Inc., a position she has held since December 2020.
  • She completed her residency in Preventive Care at Harvard Preventive Care and is Board Certified in Preventive Care and Occupational Medicine.
  • I am thrilled to join the Asensus Surgical Board of Directors at such an important time for the company, said Mr. Hobert.
  • This builds upon the foundation of Digital Laparoscopy with the Senhance Surgical System powered by the Intelligent Surgical Unit (ISU) to increase surgeon control and reduce surgical variability.

NHS Surgeon First in Europe to Implant TELA Bio's OviTex® LPR Reinforced Tissue Matrix

Retrieved on: 
Wednesday, July 21, 2021

Mr. Paul Wilson, Consultant General Surgeon at University Hospitals of Morecambe Bay NHS Foundation Trust, successfully performed Europe's first minimally invasive hernia repair with OviTex LPR.

Key Points: 
  • Mr. Paul Wilson, Consultant General Surgeon at University Hospitals of Morecambe Bay NHS Foundation Trust, successfully performed Europe's first minimally invasive hernia repair with OviTex LPR.
  • "I would like to personally thank Mr. Paul Wilson for trusting TELA Bio's OviTex Reinforced Tissue Matrix to care for your patients."
  • TELA Bio's OviTex and OviTex PRS Reinforced Tissue Matrix products are purposefully designed to address the shortcomings of existing reinforcement materials in hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery.
  • OviTex Reinforced Tissue Matrix is intended for use as a surgical mesh to reinforce and/or repair soft tissue where weakness exists.

Theator Collaborates with Mayo Clinic to Reimagine Surgical Education and Training

Retrieved on: 
Tuesday, July 20, 2021

The collaboration will enable Theator to broaden the capabilities of its market-leading Surgical Intelligence platform for use in the fields of urology and gynecology.

Key Points: 
  • The collaboration will enable Theator to broaden the capabilities of its market-leading Surgical Intelligence platform for use in the fields of urology and gynecology.
  • Mayo Clinic's collaboration with Theator demonstrates its commitment to cultivating relationships with leading providers of cutting-edge medical technology to improve surgical performance.
  • Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.
  • Theator is pioneering the Surgical Intelligence revolution, with an innovative platform built for surgeons by surgeons to address the variability and disparity in surgical care.

CytoSorbents to Report Second Quarter 2021 Operating and Financial Results

Retrieved on: 
Monday, July 19, 2021

CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification.

Key Points: 
  • CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification.
  • These are conditions where the risk of death can be extremely high, yet few to no effective treatments exist.
  • CytoSorb is also being used during and after cardiac surgery to remove inflammatory mediators that can lead to post-operative complications, including multiple organ failure.
  • For more information, please visit the Company's websites at www.cytosorbents.com and www.cytosorb.com or follow us on Facebook and Twitter .

Medical Microinstruments’ Symani® Surgical System Saves Patient’s Arm from Amputation

Retrieved on: 
Tuesday, July 13, 2021

Medical Microinstruments (MMI) SpA , a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today that MMIs Symani Surgical System was successfully used at Careggi University Hospital Florence by Prof. Marco Innocenti, M.D., and his team in a complex, post-traumatic limb reconstruction that saved a patients arm from amputation.

Key Points: 
  • Medical Microinstruments (MMI) SpA , a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today that MMIs Symani Surgical System was successfully used at Careggi University Hospital Florence by Prof. Marco Innocenti, M.D., and his team in a complex, post-traumatic limb reconstruction that saved a patients arm from amputation.
  • It was also the first time Prof. Innocenti performed a free-flap reconstruction with the fibula bone using the Symani Surgical System.
  • The Symani Surgical System received CE Mark in 2019 and can enhance free-flap reconstructions, replantations, congenital malformations, peripheral nerve repairs and lymphatic surgeries.
  • The Symani Surgical System combines proprietary innovations including the worlds smallest wristed microinstruments as well as tremor-reducing and motion-scaling technologies.

AtriCure to Announce Second Quarter 2021 Financial Results

Retrieved on: 
Wednesday, July 7, 2021

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release second quarter 2021 financial results on Wednesday, August 4, 2021.

Key Points: 
  • AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release second quarter 2021 financial results on Wednesday, August 4, 2021.
  • AtriCure will host a conference call at 4:30 p.m. Eastern Time on Wednesday, August 4, 2021 to discuss its second quarter 2021 financial results.
  • A live audio webcast of the presentation may be accessed by visiting the Investors page of AtriCures corporate website at ir.atricure.com .
  • Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications.

Global Syringes, Needles, and Urinary Catheters (Hospital Supplies) Market Report 2021: Analysis and Forecast Model with COVID-19 Market Impacts - ResearchAndMarkets.com

Retrieved on: 
Monday, July 5, 2021

The "Syringes, Needles, and Urinary Catheters (Hospital Supplies) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Syringes, Needles, and Urinary Catheters (Hospital Supplies) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" report has been added to ResearchAndMarkets.com's offering.
  • The model discusses the effect of COVID -19 on the Syringes, Needles, and Urinary Catheters market for the year 2020 and beyond.
  • Urinary catheters are used to treat patients with urinary incontinence, urinary retention, or other urological disorders.
  • Track device sales in the global and country-specific Syringes, Needles, and Urinary Catheters market from 2015-2030.